Sally A. Prigent

1.5k total citations
23 papers, 1.3k citations indexed

About

Sally A. Prigent is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Sally A. Prigent has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Sally A. Prigent's work include HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Sally A. Prigent is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Sally A. Prigent collaborates with scholars based in United Kingdom, United States and United Arab Emirates. Sally A. Prigent's co-authors include Nicholas R. Lemoine, James R. Feramisco, E A Hudson, Margaret M. Manson, Matthew Squires, B.J. Smith, Mark D. Bass, David R. Critchley, Samrein B. M. Ahmed and Martin Dickens and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.

In The Last Decade

Sally A. Prigent

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally A. Prigent United Kingdom 16 775 483 188 150 115 23 1.3k
Gianluca Bossi Italy 30 1.4k 1.7× 988 2.0× 167 0.9× 79 0.5× 14 0.1× 53 2.2k
Fei-Meng Zheng China 20 1.1k 1.5× 484 1.0× 379 2.0× 34 0.2× 37 0.3× 33 1.7k
Alfredo Castro United States 9 1.1k 1.4× 468 1.0× 91 0.5× 83 0.6× 8 0.1× 17 1.7k
Grégoire Prévost France 24 1.0k 1.3× 645 1.3× 110 0.6× 138 0.9× 6 0.1× 56 1.7k
Patrizia Marini Germany 17 929 1.2× 327 0.7× 97 0.5× 89 0.6× 9 0.1× 22 1.6k
Aline Appert-Collin France 14 414 0.5× 193 0.4× 75 0.4× 84 0.6× 7 0.1× 21 692
Franziska van Zijl Austria 11 824 1.1× 604 1.3× 177 0.9× 27 0.2× 9 0.1× 13 1.6k
Abdelhadi Rebbaa United States 21 1.0k 1.3× 293 0.6× 239 1.3× 74 0.5× 5 0.0× 46 1.6k

Countries citing papers authored by Sally A. Prigent

Since Specialization
Citations

This map shows the geographic impact of Sally A. Prigent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally A. Prigent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally A. Prigent more than expected).

Fields of papers citing papers by Sally A. Prigent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally A. Prigent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally A. Prigent. The network helps show where Sally A. Prigent may publish in the future.

Co-authorship network of co-authors of Sally A. Prigent

This figure shows the co-authorship network connecting the top 25 collaborators of Sally A. Prigent. A scholar is included among the top collaborators of Sally A. Prigent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally A. Prigent. Sally A. Prigent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Samrein B. M., et al.. (2019). Studying the ShcD and ERK interaction under acute oxidative stress conditions in melanoma cells. The International Journal of Biochemistry & Cell Biology. 112. 123–133. 3 indexed citations
2.
Ahmed, Samrein B. M., et al.. (2018). The role of the ShcD and RET interaction in neuroblastoma survival and migration. Biochemistry and Biophysics Reports. 13. 99–108. 3 indexed citations
4.
Ahmed, Samrein B. M. & Sally A. Prigent. (2017). Insights into the Shc Family of Adaptor Proteins. PubMed. 12. 2–2. 41 indexed citations
5.
Ahmed, Samrein B. M. & Sally A. Prigent. (2013). A nuclear export signal and oxidative stress regulate ShcD subcellular localisation: A potential role for ShcD in the nucleus. Cellular Signalling. 26(1). 32–40. 10 indexed citations
6.
Miller, Bryan W., et al.. (2012). Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion. Molecular and Cellular Biochemistry. 367(1-2). 31–42. 4 indexed citations
7.
Harding, Stephen J., Gareth J. Browne, Bryan W. Miller, Sally A. Prigent, & Martin Dickens. (2010). Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(9). 733–740. 24 indexed citations
8.
Squires, Matthew, E A Hudson, Lynne Howells, et al.. (2003). Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochemical Pharmacology. 65(3). 361–376. 166 indexed citations
9.
Prigent, Sally A.. (2003). Identification of Receptor Tyrosine Kinase Associating Proteins Using the Yeast Two-Hybrid System. Humana Press eBooks. 124. 251–270. 2 indexed citations
10.
Manson, Margaret M., Andreas J. Gescher, E A Hudson, et al.. (2000). Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicology Letters. 112-113. 499–505. 78 indexed citations
11.
Feramisco, James R., et al.. (2000). The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. Biochemical Journal. 347(2). 501–501. 53 indexed citations
12.
Maxwell, Anthony, et al.. (2000). Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells. Oncogene. 19(47). 5398–5405. 18 indexed citations
13.
Manson, Margaret M., Karen Holloway, Lynne Howells, et al.. (2000). Modulation of signal transduction pathways by chemopreventive agents. Biochemical Society Transactions. 28(1). A7–A7. 2 indexed citations
14.
Prigent, Sally A., Erik Kupperman, Lise Rioux, et al.. (1997). RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation. Journal of Biological Chemistry. 272(9). 5600–5605. 68 indexed citations
15.
Edman, Carl F., et al.. (1997). Identification of ErbB3-stimulated genes using modified representational difference analysis. Biochemical Journal. 323(1). 113–118. 18 indexed citations
16.
Prigent, Sally A., Motoo Nagane, Hong Lin, et al.. (1996). Enhanced Tumorigenic Behavior of Glioblastoma Cells Expressing a Truncated Epidermal Growth Factor Receptor Is Mediated through the Ras-Shc-Grb2 Pathway. Journal of Biological Chemistry. 271(41). 25639–25645. 138 indexed citations
17.
Prigent, Sally A., Tahir S Pillay, Kodi S. Ravichandran, & William J. Gullick. (1995). Binding of Shc to the NPXY Motif Is Mediated by Its N-terminal Domain. Journal of Biological Chemistry. 270(38). 22097–22100. 30 indexed citations
18.
Kita, Yoshiko, Yi Luo, Duanzhi Wen, et al.. (1994). NDF/heregulin stimulates the phosphorylation of Her3/erbB3. FEBS Letters. 349(1). 139–143. 62 indexed citations
19.
Prigent, Sally A. & Nicholas R. Lemoine. (1992). The type 1 (EGFR-related) family of growth factor receptors and their ligands. PubMed. 4(1). 1–24. 315 indexed citations
20.
Lemoine, Nicholas R., Hing Y. Leung, Claire Barton, et al.. (1992). The erbB‐3 Gene in human pancreatic cancer. The Journal of Pathology. 168(3). 269–273. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026